Homepage/Press Release/BioCanCell Presents Final Data from Phase 2 Study of BC-819 for Early Stage Bladder Cancer at the 2018 ASCO Genitourinary Cancers Symposium
Press Release
BioCanCell Presents Final Data from Phase 2 Study of BC-819 for Early Stage Bladder Cancer at the 2018 ASCO Genitourinary Cancers Symposium